Speed Dating Dementia with Lewy Bodies
Dementia with Lewy Bodies (DLB): The Essential Guide – Answers to Your Most Common Questions
Dementia with Lewy Bodies (DLB) is one of the most common forms of neurodegenerative dementia, yet it remains frequently under-recognised and misdiagnosed. Unlike Alzheimer’s disease, which typically begins with memory difficulties, DLB can affect thinking, attention, perception, movement and sleep, often in quite distinctive ways.
In this presentation, Professor Simon Lewis explores some of the most frequently asked questions about DLB, providing clear, practical answers to help patients, families and health professionals better understand this complex condition.
What causes DLB? How is it different from Alzheimer’s disease and Parkinson’s disease? Why do some people experience vivid visual hallucinations or dramatic fluctuations in their thinking and alertness? Professor Lewis explains the role of abnormal accumulation of a protein called alpha-synuclein in the brain and how this disrupts the networks responsible for cognition, movement and other essential functions.
The presentation examines the characteristic features of DLB, including changes in attention and concentration, visual hallucinations, Parkinsonian symptoms such as slowness and stiffness, and REM sleep behaviour disorder, where people physically act out their dreams. It also explores other important symptoms, including falls, fainting, constipation and disturbances of blood pressure.
How is DLB diagnosed, and what investigations can help distinguish it from other forms of dementia? Professor Lewis discusses the importance of recognising its characteristic clinical features and the role of specialist assessment and emerging diagnostic technologies.
Importantly, the presentation addresses current treatment options, including medications that can improve cognitive symptoms, strategies for managing movement difficulties, and the vital contributions of exercise, physiotherapy and other supportive therapies. Particular attention is given to the challenges of medication management, including the potential for serious adverse reactions to certain antipsychotic drugs.
Although there is currently no cure for DLB, better recognition, earlier diagnosis and appropriate multidisciplinary care can make a substantial difference to quality of life for patients and their families.